The worldwide CAR T-cell therapy market is experiencing remarkable growth, driven by growing demand for cutting-edge cancer treatment options. This accelerated expansion is fueled by elements such as the acceptance of CAR T-cell therapies for diverse treatments, advancements in manufacturing technol